Revolution Medicines, Inc. financial data

Symbol
RVMD, RVMDW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
700 Saginaw Dr, Redwood City, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.5K % +26.4%
Debt-to-equity 11.9 % -24.3%
Return On Equity -33.7 % +13.5%
Return On Assets -30.1 % +10.5%
Operating Margin -88K % -6144%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 168M shares +53.5%
Common Stock, Shares, Outstanding 168M shares +53.3%
Entity Public Float 2.76B USD +124%
Common Stock, Value, Issued 16K USD +45.5%
Weighted Average Number of Shares Outstanding, Basic 167M shares +52.7%
Weighted Average Number of Shares Outstanding, Diluted 167M shares +52.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 742K USD -97.2%
Research and Development Expense 553M USD +62.3%
General and Administrative Expense 101M USD +85.6%
Operating Income (Loss) -653M USD -77.1%
Nonoperating Income (Expense) 86.5M USD +158%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -567M USD -69%
Income Tax Expense (Benefit) 343K USD
Net Income (Loss) Attributable to Parent -567M USD -71.1%
Earnings Per Share, Basic -3.79 USD/shares -17%
Earnings Per Share, Diluted -3.79 USD/shares -17%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 201M USD -43.8%
Marketable Securities, Current 1.35B USD +196%
Assets, Current 1.58B USD +91.5%
Property, Plant and Equipment, Net 24.8M USD +22.3%
Operating Lease, Right-of-Use Asset 74.3M USD +39.9%
Intangible Assets, Net (Excluding Goodwill) 56.9M USD -1.84%
Goodwill 14.6M USD 0%
Other Assets, Noncurrent 10.3M USD -9.49%
Assets 1.76B USD +79.1%
Accounts Payable, Current 24.5M USD -17.5%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 111M USD +29.6%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Deferred Income Tax Liabilities, Net 3.12M USD -1.36%
Operating Lease, Liability, Noncurrent 78.3M USD +37.2%
Other Liabilities, Noncurrent 1.64M USD +67.4%
Liabilities 197M USD +34%
Accumulated Other Comprehensive Income (Loss), Net of Tax 3.81M USD
Retained Earnings (Accumulated Deficit) -1.54B USD -58.1%
Stockholders' Equity Attributable to Parent 1.57B USD +87%
Liabilities and Equity 1.76B USD +79.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -161M USD -157%
Net Cash Provided by (Used in) Financing Activities 810K USD -99.8%
Net Cash Provided by (Used in) Investing Activities -248M USD -6305%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 173M shares +58.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -408M USD -253%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 204M USD -43.4%
Deferred Tax Assets, Valuation Allowance 377M USD +68.1%
Deferred Tax Assets, Gross 404M USD +61.2%
Operating Lease, Liability 86.7M USD +38%
Depreciation 6.08M USD +24.6%
Payments to Acquire Property, Plant, and Equipment 3.17M USD +80.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -562M USD -70.5%
Lessee, Operating Lease, Liability, to be Paid 139M USD +31.5%
Property, Plant and Equipment, Gross 46.5M USD +21.2%
Operating Lease, Liability, Current 8.4M USD +45.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 10.8M USD +47.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 10.5M USD +47.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 51.9M USD +24.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.2M USD +47.5%
Deferred Tax Assets, Operating Loss Carryforwards 148M USD +11.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 191M USD +2418%
Lessee, Operating Lease, Liability, to be Paid, Year Four 11.6M USD +47.5%
Operating Lease, Payments 2.3M USD -14.3%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.07M USD -0.09%
Depreciation, Depletion and Amortization 1.21M USD +33.7%
Deferred Tax Assets, Net of Valuation Allowance 26.9M USD +2.39%
Share-based Payment Arrangement, Expense 82.2M USD +84%
Interest Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%